Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Liver Cancer
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Liver Cancer
    TopAbstracts in Liver Cancer 11/27/2008 - (DGNews)
    Annual Report Finds Declines in Cancer Incidence and Death in US, But Wide Variation in Lung Cancer Trends - (DGNews)
    TopAbstracts in Liver Cancer 11/13/2008 - (DGNews)
    Sorafenib Improves Markers of Survival in Patients With Liver Cancer: Presented at AASLD - (DGDispatch)
    TopAbstracts in Liver Cancer 10/30/2008 - (DGNews)

    News archive

     Recent webcasts/CME - Liver Cancer

    Webcasts/CME archive

     Recent cases - Liver Cancer
      Complete Clinical Response of Metastatic Hepatocellular Carcinoma to Sorafenib in a Patient with Hemochromatosis: A Case Report
      Isolated Metastatic Extremity Liposarcoma to the Liver, an Uncommon and Transient Finding
      Primary Carcinoid Tumors of the Liver
      Acute Liver Failure Due to Primary Angiosarcoma : A Case Report and Review of Literature
      Primary Hepatic Lymphoma Presenting as Fulminant Hepatic Failure With Hyperferritinemia: A Case Report

      Cases archive
        




      my personal edition > liver cancer > news
      divider

        E-Mail this DGReview to a colleague

      DGReview


      Intra-Arterial Folinic Acid and 5-Flurouracil Effective in Locally Advanced Hepatocarcinoma

      A DGReview of :"Treatment of locally advanced hepatocellular carcinoma by hepatic intra-artery chemotherapy: a pilot study"
      Digestive and Liver Disease

      05/19/2004
      By Emma Hitt, PhD


      Intra-arterial folinic acid and 5-flurouracil may benefit cirrhotic patients with locally advanced hepatocarcinoma, even in the presence of thrombosis, new research suggests.

      Hepatocarcinoma generally has a poor prognosis, and the optimal treatment of locally advanced hepatocarcinoma remains controversial. Transcatheter arterial chemoembolisation of hepatocarcinoma is widely used but has not been fully investigated.

      Roberto Mazzanti, MD, with the School of Medicine at the University of Florence, Italy, and colleagues wanted to determine whether intra-arterial chemotherapy with 5-flurouracil and folinic acid in locally advanced hepatocarcinoma is a viable alternative to existing therapies.

      The researchers enrolled 24 consecutive inoperable patients (19 men and 5 women) with locally advanced hepatocarcinoma. Median age was 69 years, range 48 to 80 years.

      Diagnosis of hepatocellular carcinoma was confirmed by ultrasound-guided liver biopsy and histopathological examination. Seven patients with portal vein thrombosis were also included in the study. Of them, 6 were affected by Child A stage cirrhosis and 1 had Child B stage cirrhosis.

      All patients received intra-arterial chemotherapy via a surgically implanted port-a-cath. Folinic acid (100 mg/m2) and 5-flurouracil (up to 550 mg/m2) were administered on a 1-week or a 2-week schedule.

      Of the 19 patients who completed the study, 2 completely responded, 11 partially responded, 6 had stable disease, and 4 showed disease progression. Median survival time was 19 (range 4-85) months. Child A patients showed a significant longer survival than Child B patients (P < .005).

      However, no significant difference in survival was found between patients with or without portal vein thrombosis or between patients who had or had not undergone previous therapy. In addition, no hepatic or systemic toxicity was observed following 5-FU administration.

      "Intra-arterial chemotherapy appears to be a possible strategy in the treatment of locally advanced hepatocellular carcinoma in cirrhotic patients, even in the presence of portal thrombosis," they conclude.


      Dig Liver Dis 2004;36:278-285. "Treatment of locally advanced hepatocellular carcinoma by hepatic intra-artery chemotherapy: a pilot study"

      E-Mail this DGReview to a colleague   To print, use this version






      All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send